Only challenge is current liabilities. They need money on the table and net free cashflow is not sufficient to match those short term liabilities. According to the financial report they have to coke up with approx 90M USD to meet obligations for the coming 1-4 months.. That's why the stock is surpressed and will fly when resolved. It will be in the best interest for creditors to cut them some slack and extend payment deadlines.. However still a tricky situation.. The GH infusion would have definitily skyrocketed banro. Now everything is one big question mark..
Nutsy, as long as the company is able to pay debt down, quarter by quarter, they will do well because refinancing will not be a problem. They are well on their way to turning a profit, Q over Q, so reducing total debt should be no problem. If the market agrees, we will see the stock price continue to move up from here.
Market Data 
Markets 
